Cite
HARVARD Citation
Sakashita, H. et al. (2022). A phase II feasibility study of carboplatin and nab‐paclitaxel for advanced non‐small cell lung cancer patients with interstitial lung disease (YLOG0114). Thoracic cancer. 13 (9), pp. 1267-1275. [Online].